Unique ID issued by UMIN | UMIN000003070 |
---|---|
Receipt number | R000003724 |
Scientific Title | Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children |
Date of disclosure of the study information | 2010/01/21 |
Last modified on | 2011/04/08 14:09:51 |
Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children
Efficacy of low dose budesonide inhalation for mild / moderate persistent asthma in young children (Mild One Study)
Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children
Efficacy of low dose budesonide inhalation for mild / moderate persistent asthma in young children (Mild One Study)
Japan |
bronchial asthma
Pneumology | Clinical immunology | Pediatrics |
Others
NO
To evaluate efficacy of budesonide inhalation suspension 0.25 mg qd (1 inh./day) administrate on 12 weeks for mild / moderate persistent bronchial asthma in young children.
Moreover to evaluate efficacy sodium cromoglicate inhalation solution (for nebulizer use), the standard for nonsteroidal therapy, on same terms as a reference.
To collect preliminary data for large scale clinical test.
Efficacy
Daytime and nighttime symptom score at baseline and after 12 weeks of administration (0-3 point scale).
- Score of symptom (based on asthma diary, 0-9 point scale)
- Frequency of use inhaled short acting beta2 agonist(SABA)
- Level of blood serum cortisol at baseline and end of study
- Level of blood serum ECP at baseline and end of study
- Unscheduled hospital visits and emergency room visit because of asthma exacerbation
- Adverse events
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is not considered as adjustment factor.
Central registration
2
Treatment
Medicine |
BIS administration group
Budesonide inhalation suspension 0.25 mg, once daily before bed for 12 weeks using jet nebulizer (PARI TurboBOY N, PARI LC Plus Nebulizer)
CIS administration group
Sodium cromoglicate inhalant solution 20 mg, 3 times daily (morning, afternoon (or evening), before bedtime) for 12 weeks using jet nebulizer (PARI TurboBOY N, PARI LC Plus Nebulizer)
6 | months-old | <= |
60 | months-old | > |
Male and Female
Mild to moderate persistent asthma patients (JPGL 2005, Pediatr Int. 2007 Dec;49(6):1023-31)
1. Patients who have a case listed below within a month
a)Severe respiratory infection disease that required hospitalization
b)Administration of systemic steroid
2. Patients who have underlying disease that indicate chronic airway symptom exclude asthma
40
1st name | |
Middle name | |
Last name | Toshio Katsunuma |
Jikei University School of Medicine
Department of Pediatrics
3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan
1st name | |
Middle name | |
Last name | Toshio Katsunuma |
Jikei University School of Medicine
Department of Pediatrics
3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan
Mild One research society
Japan Allergy Foundation
Non profit foundation
NO
東京慈恵会医科大学(東京都)
町立津南病院(新潟県)
国立成育医療センター(東京都)
富山大学(富山県)
獨協医科大学(栃木県)
富山赤十字病院(富山県)
慈愛会今村病院(鹿児島県)
やのファミリークリニック(鹿児島県)
おのうえこどもクリニック(富山県)
糸魚川総合病院(新潟県)
吉原医院(栃木県)
2010 | Year | 01 | Month | 21 | Day |
Unpublished
Completed
2007 | Year | 05 | Month | 31 | Day |
2008 | Year | 05 | Month | 01 | Day |
2010 | Year | 08 | Month | 01 | Day |
2010 | Year | 01 | Month | 21 | Day |
2011 | Year | 04 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003724